Bg pattern

AMINOPLASMAL PO 12.5% SOLUTION FOR INFUSION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use AMINOPLASMAL PO 12.5% SOLUTION FOR INFUSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet:information for theuser

Aminoplasmal PO 12.5% solution for infusion

Read the entire leaflet carefully before starting to use the medicine.

  • Keep this leaflet, as you may need to read it again.
  • If you have any doubts, consult your doctor or pharmacist.
  • This medicine has been prescribed to you personally and should not be given to others, even if they have the same symptoms, as it may harm them.
    • If you consider that any of the adverse effects you are suffering from is serious or if you notice any adverse effect not mentioned in this leaflet, inform your doctor or pharmacist.

Contents of the leaflet:

  1. What Aminoplasmal PO 12.5% is and what it is used for
  2. Before using Aminoplasmal PO 12.5%
  3. How to use Aminoplasmal PO 12.5%
  4. Possible side effects
    1. Storage of Aminoplasmal PO 12.5%
    2. Additional information

1. What Aminoplasmal PO 12.5% is and what it is used for

Aminoplasmal PO 12.5% is a nutritional supplement for intravenous administration, which contains essential substances for the body's functions.

It is used to cover the body's needs for protein and fluid after surgical interventions and traumas.

The administration of this solution should always be combined with an adequate intake of calories (glucose solutions or fat emulsions).

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Before using Aminoplasmal PO 12.5%

Do not use Aminoplasmal PO 12.5%

  • If you are allergic (hypersensitive) to any of the components of Aminoplasmal PO 12.5%.
  • If you are allergic to any amino acid

Be careful with Aminoplasmal PO 12.5%

If you have:

  • any congenital anomaly (problem that exists at birth) of amino acid metabolism (degradation)
  • severe liver disease
  • kidney function disorder with abnormal values in residual nitrogen levels
  • hyperkalemia (excess potassium in the blood)
  • hyperhydration (excess water in the body)
  • manifest heart failure
  • acidic substances accumulated in your blood (metabolic acidosis)

Aminoplasmal PO 12.5% should not be used in premature and newborn babies

The levels of fluids and electrolytes, acid balance, should be regularly checked to be correct.

Maximum duration of administration: up to 7 days, after an operation (post-operative state) or after an accident (post-traumatic state).

Your doctor should regularly check that the levels of fluids and electrolytes, blood sugar, serum proteins, acid-base balance, and liver and kidney function are correct.

Use of other medicines

Tell your doctor or pharmacist if you are using or have recently used other medicines, including those purchased without a prescription.

Amino acid solutions like Aminoplasmal PO 12.5% should not be used as carrier solutions for other medicines. If they are mixed with other medicines, reactions may occur that could spoil the solution.

Pregnancy and breastfeeding

Aminoplasmal PO 12.5% should not be administered during the first three months of pregnancy.

During the rest of the pregnancy, your doctor will decide, after assessing the possible benefits and risks of administering Aminoplasmal PO 12.5%, if you can take this medicine.

Consult your doctor or pharmacist before using any medicine.

Driving and using machines

Not applicable

3. How to use Aminoplasmal PO 12.5% solution for infusion

Your doctor will determine the amount you need daily. The normal dose is 8-16 ml per kg of body weight and per day (1-2 g of amino acids per kg of body weight and day).

For optimal utilization of amino acids, it is recommended that 100-200 kcal per gram of nitrogen be administered simultaneously with Aminoplasmal PO 12.5%.

Follow exactly the administration instructions of Aminoplasmal PO 12.5% indicated by your doctor. Consult your doctor or pharmacist if you have doubts.

If you use more Aminoplasmal PO 12.5% than you should

It is unlikely that this will happen since your doctor will determine your daily doses. However, if you receive an overdose or the solution is administered too quickly, you may lose some amino acids in the urine, and you may feel nausea, chills, or vomiting. These symptoms will disappear as soon as the infusion is interrupted or the speed of the infusion is reduced.

If you have used more Aminoplasmal PO 12.5% than you should, consult your doctor, pharmacist, or call the Toxicology Information Service immediately. Telephone 91-562 04 20, indicating the medicine and the amount used.

If you have any other doubts about the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, Aminoplasmal PO 12.5% solution can cause side effects, although not everyone gets them.

The frequency of side effects is classified into the following categories:

Very common

At least 1 in 10 patients

Common

At least 1 in 100 patients

Uncommon

At least 1 in 1,000 patients

Rare

At least 1 in 10,000 patients

Very rare

In less than 1 in 10,000 patients, including isolated reports

The following side effects have been reported when administering Aminoplasmal PO 12.5% solution:

Gastrointestinal disorders

Uncommon: nausea and vomiting

General disorders and administration site conditions:

Uncommon: headache, chills, and fever.

In addition, if the administration of the solution is too rapid, losses of amino acids in the urine with the consequent imbalance in their levels may occur, apart from the adverse reactions described.

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency's website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Aminoplasmal 12.5% solution for infusion

Keep out of the reach and sight of children.

No special storage conditions are required. Keep the container in the outer packaging to protect it from light. Do not freeze.

Do not use Aminoplasmal PO 12.5% after the expiration date stated on the container. The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the container and any unused medicine. This will help protect the environment.

6. Additional information

Composition of Aminoplasmal PO 12.5%:

Per 1 ml

Per 500 ml

Isoleucine

6,000 mg

3,000 g

Leucine

10,500 mg

5,250 g

Lysine Acetate

(equivalent to lysine 9.24 mg)

13,038 mg

6,519 g

Methionine

2,500 mg

1,250 g

Phenylalanine

5,250 mg

2,625 g

Threonine

6,000 mg

3,000 g

Tryptophan

2,500 mg

1,250 g

Valine

8,000 mg

4,000 g

Arginine

10,750 mg

5,375 g

Histidine

6,750 mg

3,375 g

Glycine

8,750 mg

4,375 g

Alanine

15,500 mg

7,750 g

Proline

8,750 mg

4,375 g

Aspartic Acid

1,125 mg

0,562 g

Asparagine monohydrate

(equivalent to Asparagine 1.122 mg/ml)

1,275 mg

0,637 g

Acetylcysteine

(equivalent to Cysteine 0.73 mg/ml)

1,000 mg

0,500 g

Glutamic Acid

11,250 mg

5,625 g

Ornithine hydrochloride

(equivalent to ornithine 2.25 mg/ml)

2,875 mg

1,437 g

Serine

4,000 mg

2,000 g

Acetyltyrosine

(equivalent to Tyrosine 2.50 mg/ml)

3,075 mg

1,537 g

Electrolytes

mmol/l

mEq/l

Chlorides

17

17

Acetates

63.2

63.2

Total Amino Acids

123 g/l

Total Nitrogen

19 g/l

Protein Equivalent

121 g/l

Theoretical Osmolality

1026 mOsm/l

pH

5.0 – 7.5

AAE/AAT

0.4

Energy Value

? 500kcal/l

The other components are: citric acid and water for injectable preparations.

Appearance of the product and contents of the container

Aminoplasmal PO 12.5% is a clear, colorless or slightly straw-colored solution for infusion, presented in glass vials, closed with rubber stoppers.

This medicine is presented in 500 ml vials.

Marketing authorization holder and manufacturer

Marketing authorization holder:

  • Braun Medical, S.A.

Ctra. de Terrassa, 121

08191-Rubí (Barcelona)

Spain

Manufacturer:

  • Braun Melsungen AG

Carl-Braun Straße, 1

34212 Melsungen

Germany

This leaflet was approved in June 2015.

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products.

---------------------------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals:

Single-use containers. Discard any unused contents after completing the infusion.

The solution should only be used if the container closure is not damaged and the solution is clear.

Use the sterile administration set for administration.

If it is necessary to add other nutrients such as carbohydrates, lipids, vitamins, and trace elements to this medicine in total parenteral nutrition, the addition should be performed under strict aseptic conditions. Mix well after adding any additive. Pay special attention to compatibility.

The disposal of unused medicine and all materials that have come into contact with it will be carried out in accordance with local regulations.

Online doctors for AMINOPLASMAL PO 12.5% SOLUTION FOR INFUSION

Discuss questions about AMINOPLASMAL PO 12.5% SOLUTION FOR INFUSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for AMINOPLASMAL PO 12.5% SOLUTION FOR INFUSION?
AMINOPLASMAL PO 12.5% SOLUTION FOR INFUSION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in AMINOPLASMAL PO 12.5% SOLUTION FOR INFUSION?
The active ingredient in AMINOPLASMAL PO 12.5% SOLUTION FOR INFUSION is amino acids. This information helps identify medicines with the same composition but different brand names.
Who manufactures AMINOPLASMAL PO 12.5% SOLUTION FOR INFUSION?
AMINOPLASMAL PO 12.5% SOLUTION FOR INFUSION is manufactured by B Braun Medical S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of AMINOPLASMAL PO 12.5% SOLUTION FOR INFUSION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether AMINOPLASMAL PO 12.5% SOLUTION FOR INFUSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to AMINOPLASMAL PO 12.5% SOLUTION FOR INFUSION?
Other medicines with the same active substance (amino acids) include AMINOPLASMAL B.BRAUN 10% E SOLUTION FOR INFUSION, AMINOPLASMAL B.BRAUN 10% SOLUTION FOR INFUSION, AMINOPLASMAL B.BRAUN 15% SOLUTION FOR INFUSION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media